Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences
11/01/2022 - 04:15 PM
DUBLIN , Nov. 1, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in the following upcoming investor conferences:
Jefferies London Healthcare Conference on Tuesday, November 15, 2022
The presentation is scheduled for 5:20 a.m. ET / 10:20 a.m. GMT . 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022
The presentation is scheduled for 1:50 p.m. ET / 6:50 p.m. GMT . Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022
The presentation is scheduled for 12:00 p.m. ET / 5:00 p.m. GMT . Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com . Replays of the webcasts will be archived on the website for 30 days following the conferences.
About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.
Contacts:
Investors: Andrea N. Flynn , Ph.D. Vice President, Head, Investor Relations Jazz Pharmaceuticals plcInvestorInfo@jazzpharma.com Ireland +353 1 634 3211 U.S. +1 650 496 2717
Media: Kristin Bhavnani Head of Global Corporate Communications Jazz Pharmaceuticals plcCorporateAffairsMediaInfo@jazzpharma.com Ireland +353 1 637 2141 U.S. +1 215 867 4948
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-november-investor-conferences-301665345.html
SOURCE Jazz Pharmaceuticals plc
JAZZ Rankings
#2855 Ranked by Stock Gains
JAZZ Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Other, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
Ireland
City
Dublin
About JAZZ
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni